Stock News Reunion Neuroscience struggles to maintain Nasdaq listing requirements The company has until mid-October to fulfill the requirements before the exchange takes further action Rowan DunneApril 26, 2023
News Mindset Pharma files patents for non-hallucinogenic, ‘psychedelic-inspired’ drugs The company believes the drugs have the potential to treat children and seniors Natalia Buendia CalvilloApril 26, 2023
Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023
Psychedelics International psychedelics market to reach US$8.3B by 2027: ReportLinker The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent Rowan DunneApril 24, 2023
Psychedelics Mydecine’s MDMA with rapid onset and a short duration shows promising results The effects from the company's MYCO-006 compounds last for only two hours and set in four times as fast Rowan DunneApril 24, 2023
News Lobe Sciences acquires rare blood disease treatment company Lobe's primary focus is psychedelic medicines but the company also has an interest in treating rare disorders Rowan DunneApril 18, 2023
News Numinus Wellness YoY revenue increased five times to $5.4M Numinus clinic network generated $4.7 million in revenue during Q2 2023, showing a significant increase of 596.9 per cent from the same period last... Natalia Buendia CalvilloApril 13, 2023
News Psilocybin decreases depression in cancer patients: study Depression impacts 1 in 4 people with cancer and often becomes a debilitating aspect of their diagnosis Natalia Buendia CalvilloApril 13, 2023
News Numinus Wellness launches new psychedelics clinic licensing model for independent practitioners The company also partnered with Healing CREI to offer full operational clinics to their licensees Natalia Buendia CalvilloApril 11, 2023
Psychedelics MGC Pharma gets permission from Slovenian health authorities to research psilocybin MGC says it is the first company operating in Slovenia to obtain permission to engage in studies on the psychedelic compound Rowan DunneApril 5, 2023